Importantly, the signal intensity of IL-33 in dermal fibroblasts was modestly but significantly elevated in BLM-treated Fli1+/− mice compared with untreated Fli1+/− mice (Additional file 2: Figure S2). Here, FLI1 is linked to Bloom syndrome.